Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer

Bladder cancer (BCa) is one of the most common malignant tumors in the urinary system. Developing effective prognostic gene and exploring the immune cells that affect the prognosis of tumor are required. Full transcriptome data (n = 433), clinical information (n = 581) and mutation sequencing (n = 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ning, Wu, Tiange, Ma, Yuexian, Cheng, Hong, Li, Wenchao, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815815/
https://www.ncbi.nlm.nih.gov/pubmed/36206128
http://dx.doi.org/10.1097/CAD.0000000000001399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815815/
https://www.ncbi.nlm.nih.gov/pubmed/36206128
http://dx.doi.org/10.1097/CAD.0000000000001399

Ejemplares similares